About Omnicals Pharma Private Limited
Data last updated:
Omnicals Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 17 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33309MH2017PTC294976. Its GSTIN is 27AACCO5003E1ZX (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹20.75 Lakh. It is led by directors including Anurag Bhoop Narayan Pathak (Managing Director) and Rohit Dansingh Negi.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹83.93 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹8.66 Cr (net margin 10.3%) and EBITDA of ₹11.37 Cr (EBITDA margin 13.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 84% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Omnicals Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website omnicals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressFlat No 43 Raheja Bldg 2B Windermere Oshiwara Link Road Near Mhada Lokhanwalla Andh, Eri West, Mumbai, Maharashtra, India – 400053
- IndustryBusiness Outsourcing, Business & IT Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Omnicals Pharma Private Limited
The main business activities of Omnicals Pharma are trade and professional, scientific and technical. In detail, this covers wholesale trading and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Omnicals Pharma Private Limited FY 2025 filings available
Omnicals Pharma Private Limited reported revenue of ₹83.93 Cr (up 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Omnicals Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 84% over five years, including 41% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Omnicals Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.37 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.66 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Omnicals Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Omnicals Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Omnicals Pharma Private Limited
Omnicals Pharma Private Limited is compared with the companies closest to it by revenue in the Outsourcing industry (Consulting Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sahi Logistics & Infra Private Limited | ₹85.18 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Pace Financial Tresor Private Limited | ₹84.98 Cr (FY 2025) | •••• | •••• | 1496.0% | •••• | Delhi, India |
| Acyuta Services Private Limited | ₹84.77 Cr (FY 2022) | •••• | •••• | 1765.0% | •••• | Mumbai, Maharashtra, India |
| Sound Capital Markets Limited | ₹84.48 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Mumbai, Maharashtra, India |
| Dolby Technology India Private Limited | ₹84.47 Cr (FY 2025) | •••• | •••• | 62.0% | •••• | Mumbai, Maharashtra, India |
| Omnicals Pharma Private Limited this company | ₹83.93 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Mumbai, Maharashtra, India |
| Holtec Consulting Pvt. Ltd. | ₹83.81 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Samagra Development Associates Private Limited | ₹83.71 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Delhi, India |
| Great Employers Private Limited | ₹83.6 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Mumbai, Maharashtra, India |
| Decision Point Private Limited | ₹83.55 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Gurgaon, Haryana, India |
| Sattva Media and Consulting Private Limited | ₹83.47 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Omnicals Pharma by revenue in the Outsourcing industry (Consulting Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Omnicals Pharma Private Limited
Omnicals Pharma Private Limited is audited by V.A. PANJWANI & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V.A. PANJWANI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Omnicals Pharma Private Limited
Omnicals Pharma has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Dansingh Negi Also directs: Omnicrux Life Sciences Private Limited, Omnikam Private Limited | Director | 17 May 2017 | 9 Years 4 Months | Current |
| Anurag Bhoop Narayan Pathak | Managing Director | 08 Aug 2017 | 9 Years 2 Months | Current |
| Anil Kashiram Fokmare Also directs: Omnicrux Life Sciences Private Limited, Omnikam Private Limited | Director | 15 Dec 2022 | 3 Years 9 Months | Current |
| Akshya Kumar Mahapatra | Additional Director | 15 Dec 2025 | 0 Years 9 Months | Current |
Ownership and Shareholding of Omnicals Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Omnicals Pharma Private Limited
Omnicals Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Omnicals Pharma Private Limited
Omnicals Pharma operates one associated brand: Omnicals Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides marketing services for pharmaceutical products. | omnicals.com |
Employees and EPFO Compliance at Omnicals Pharma Private Limited
Omnicals Pharma Private Limited has a workforce of 14 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Omnicals Pharma Private Limited
Omnicals Pharma has 3 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Recent Activity on Omnicals Pharma Private Limited
Omnicals Pharma Private Limited has 11 board changes on record since 2017: 5 appointments and 6 cessations. The latest: Akshya Kumar Mahapatra was appointed as Additional Director on 15 Dec 2025.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Omnicals Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Omnicals Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Omnicals Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Omnicals Pharma Private Limited
Omnicals Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCO5003E1ZX | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Omnicals Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omnicals Pharma Private Limited
Omnicals Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 17 May 2017 (9+ years old) and is registered under CIN U33309MH2017PTC294976.
Omnicals Pharma reported revenue of ₹83.93 Cr for FY 2025 (up 41% YoY).
Omnicals Pharma has 4 current directors:
- Anurag Bhoop Narayan Pathak - Managing Director
- Rohit Dansingh Negi - Director
- Anil Kashiram Fokmare - Director
- Akshya Kumar Mahapatra - Additional Director
Omnicals Pharma reported a net profit of ₹8.66 Cr (net margin 10.3%) and EBITDA of ₹11.37 Cr (EBITDA margin 13.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Omnicals Pharma is 16% over three years and 84% over five years. In the latest year (FY 2025) revenue rose 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Omnicals Pharma is 27AACCO5003E1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Omnicals Pharma is U33309MH2017PTC294976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omnicals Pharma was incorporated on 17 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Omnicals Pharma by revenue are Sahi Logistics & Infra Private Limited, Pace Financial Tresor Private Limited, Acyuta Services Private Limited, Sound Capital Markets Limited, Dolby Technology India Private Limited and 5 more, all in the Outsourcing industry (Consulting Services).
Akshya Kumar Mahapatra was appointed as Additional Director on 15 Dec 2025. Anil Kashiram Fokmare ceased to be Additional Director on 08 Nov 2023. Nidhi Anurag Pathak ceased to be Additional Director on 08 Nov 2023. Omnicals Pharma has 11 board changes on record in total.
Omnicals Pharma can be reached through the website omnicals.com. Its registered office is in Mumbai, Maharashtra, India.